Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022

  • ID: 4240106
  • Report
  • Region: Global
  • 130 Pages
  • Markets and Markets
1 of 6
The Global Vascular Closure Devices Market is Expected to Reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%

FEATURED COMPANIES

  • Arstasis Inc. (U.S.)
  • Chitogen Inc. (U.S.)
  • Endocor GmbH (Germany)
  • Hemostasis LLC (U.S.)
  • Medtronic PLC (Ireland)
  • Scion Biomedical (U.S.)
  • MORE

The market is segmented on the basis of type, access, procedure, and geography. The type segment includes passive approximators, active approximators, and external hemostasis devices. The passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. Passive approximators are the most commonly used vascular closure devices in the market owing to their increased safety and fewer complications than manual procedures.

On the basis of procedures, the vascular closure devices market includes interventional cardiology and interventional radiology/vascular surgery. The interventional cardiology segment is expected to hold the largest share of the market in 2017. This can primarily be attributed to the rapidly increasing obese population and the high prevalence of cardiovascular diseases across the globe.

The access segment includes femoral and radial. The femoral access segment is estimated to account for the largest share of the market in 2017 owing to fewer complications involved during arterial access and the preference of cardiologists and physicians for conducting interventional procedures through femoral access.

Acquisitions and product approvals were the dominant strategies adopted by key industry participants to increase their market shares and cater to unmet needs. Major players include Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), and Cardiva Medical Inc. (U.S.). Other players include Morris Innovative, Inc. (U.S.), Medtronic plc (Ireland), Essential Medical, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), TZ Medical, Inc. (U.S.), and Vasorum Ltd. (Ireland).

Research Coverage:

This report studies the vascular closure devices market based on type, access, procedure, and geography. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report also forecasts the revenues of the market segments with respect to four main regions.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of the top players in the vascular closure devices market and detailed insights on the upcoming technologies, R&D activities, and product launches
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the vascular closure devices market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the market for various vascular closure devices across geographies
  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the vascular closure devices market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Arstasis Inc. (U.S.)
  • Chitogen Inc. (U.S.)
  • Endocor GmbH (Germany)
  • Hemostasis LLC (U.S.)
  • Medtronic PLC (Ireland)
  • Scion Biomedical (U.S.)
  • MORE
1 Introduction

    1.1 Objectives of the Study

    1.2 Market Definition

           1.2.1 Markets Covered

           1.2.2 Years Considered for the Study

    1.3 Currency

    1.4 Limitations

    1.5 Stakeholders

2 Research Methodology

    2.1 Research Methodology Steps

    2.2 Secondary and Primary Research Methodology

           2.2.1 Secondary Research

                    2.2.1.1 Key Data From Secondary Sources

           2.2.2 Primary Research

                    2.2.2.1 Key Data From Primary Sources

                    2.2.2.2 Key Insights From Primary Sources

                    2.2.2.3 Key Industry Insights

    2.3 Market Size Estimation Methodology

    2.4 Market Data Validation and Triangulation

    2.5 Assumptions of the Study

3 Executive Summary

4 Premium Insights

    4.1 Vascular Closure Devices: Market Overview

    4.2 Geographic Analysis: Vascular Closure Devices Market, By Type (2017)

    4.3 Market, By Access, 2017 vs 2022

    4.4 Market, By Procedure, 2017 vs 2022

    4.5 Geographic Snapshot of the Vascular Closure Devices Market

5 Market Overview

    5.1 Introduction

    5.2 Market Dynamics

           5.2.1 Drivers

                    5.2.1.1 Large Number of Approvals for Vascular Closure Devices

                    5.2.1.2 High Prevalence of Cardiovascular Diseases

                    5.2.1.3 Increasing Prevalence of Obesity

                    5.2.1.4 Increasing Focus of Market Players on Large-Bore Vascular Closure Devices

           5.2.2 Restraints

                    5.2.2.1 Increasing Preference for Interventional Procedures Using Radial Artery Access

                    5.2.2.2 High Cost of Vascular Closure Devices

                    5.2.2.3 Product Recalls and Failures

           5.2.3 Opportunity

                    5.2.3.1 Emerging Markets Providing Growth Opportunities for Market Players

           5.2.4 Challenges

                    5.2.4.1 Need for Highly Skilled Professionals

                    5.2.4.2 Risks Associated With Vascular Closure Devices

6 Global Vascular Closure Devices Market, By Type

    6.1 Introduction

    6.2 Passive Approximators

           6.2.1 Collagen Plugs

           6.2.2 Sealant Or Gel-Based Devices

           6.2.3 Compression Assist Devices

    6.3 Active Approximators

           6.3.1 Suture-Based Devices

           6.3.2 Clip-Based Devices

    6.4 External Hemostatic Devices

7 Global Vascular Closure Devices Market, By Access

    7.1 Introduction

    7.2 Femoral Access

    7.3 Radial Access

8 Global Vascular Closure Devices Market, By Procedure

    8.1 Introduction

    8.2 Interventional Cardiology

    8.3 Interventional Radiology/Vascular Surgery

9 Global Vascular Closure Devices Market, By Region

    9.1 Introduction

    9.2 North America

           9.2.1 U.S.

                    9.2.1.1 Rising Prevalence of Cardiovascular Diseases

                    9.2.1.2 Growing Trend of One-Day Surgeries for Vascular Procedures

                    9.2.1.3 Increase in Research and Clinical Trials for Vascular Closure Devices

                    9.2.1.4 Increasing Number of Conferences, Meetings, Symposia, and Workshops

           9.2.2 Canada

                    9.2.2.1 Increasing Number of Cardiac Arrest Cases

                    9.2.2.2 Long Waiting Times for Cardiac Surgery Likely to Encourage the Adoption of Minimally Invasive Procedures

    9.3 Europe

           9.3.1 Increasing Focus of Market Players in the European Region

           9.3.2 E-3

                    9.3.2.1 Increasing Number of Research Studies on Vascular Closure Devices in Germany

                    9.3.2.2 Rising Prevalence of CVDS in Germany

                    9.3.2.3 Increase in the Number of Radial Access Procedures in France and the U.K.

                    9.3.2.4 Growth in the Aging and Obese Populations in the U.K.

           9.3.3 RoE

    9.4 Asia-Pacific

           9.4.1 Rapid Growth in the Aging Population in Japan & China

           9.4.2 Cost - A Major Concern for Interventional Procedures in India

           9.4.3 Healthcare Reforms, Government Initiatives, and Investments in China and Japan

    9.5 Rest of the World

10 Competitive Landscape

     10.1 Introduction

     10.2 Vendor Dive Overview

             10.2.1 Vanguards

             10.2.2 Innovators

             10.2.3 Emerging Players

             10.2.4 Dynamic Players

     10.3 Competitive Benchmarking

             10.3.1 Analysis of the Product Portfolio of Major Players in the Market (23 Companies)

             10.3.2 Business Strategies Adopted By Major Players in the Market (23 Companies)

11 Company Profiles

     11.1 Terumo Corporation

     11.2 Abbott Laboratories

     11.3 Cardinal Health, Inc. (Cordis)

     11.4 Cardiva Medical, Inc.

     11.5 Medtronic PLC

     11.6 Morris Innovative, Inc.

     11.7 Essential Medical, Inc.

     11.8 Merit Medical Systems, Inc.

     11.9 Vasorum Ltd.

     11.10 TZ Medical, Inc.

     11.11 Vivasure Medical Ltd.

     11.12 Inseal Medical Ltd.

     11.13 Tricol Biomedical, Inc.

List of Tables
Table 1 Global Vascular Closure Devices Market, By Type, 2015-2022 (USD Million)
Table 2 Market for Passive Approximators, By Region, 2015-2022 (USD Million)
Table 3 Market for Passive Approximators, By Type, 2015-2022 (USD Million)
Table 4 Collagen Plugs Market, By Region, 2015-2022 (USD Million)
Table 5 Sealant Or Gel-Based Devices Market, By Region, 2015-2022 (USD Million)
Table 6 Compression Assist Devices Market, By Region, 2015-2022 (USD Million)
Table 7 Market for Active Approximators, By Region, 2015-2022 (USD Million)
Table 8 Market for Active Approximators, By Type, 2015-2022 (USD Million)
Table 9 Suture-Based Devices Market Size, By Region, 2015-2022 (USD Million)
Table 10 Clip-Based Devices Market Size, By Region, 2015-2022 (USD Million)
Table 11 Vascular Closure Devices Market for External Hemostatic Devices, By Region, 2015-2022 (USD Million)
Table 12 Market Size, By Access, 2015-2022 (USD Million)
Table 13 Market Size for Femoral Access, By Region, 2015-2022 (USD Million)
Table 14 Market Size for Radial Access, By Region, 2015-2022 (USD Million)
Table 15 Market Size, By Procedure, 2015-2022 (USD Million)
Table 16 Market Size for Interventional Cardiology, By Region, 2015-2022 (USD Million)
Table 17 Market Size for Interventional Radiology/Vascular Surgery, By Region, 2015-2022 (USD Million)
Table 18 Market Size, By Region, 2015-2022 (USD Million)
Table 19 North America: Vascular Closure Devices Market Size, By Country, 2015-2022 (USD Million)
Table 20 North America: Market Size, By Type, 2015-2022 (USD Million)
Table 21 North America: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 22 North America: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 23 North America: Market Size, By Access, 2015-2022 (USD Million)
Table 24 North America: Market Size, By Procedure, 2015-2022 (USD Million)
Table 25 Indicative List of Recent Conferences/Meetings/Symposia/Workshops Held in the U.S.
Table 26 U.S.: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 27 U.S.: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 28 U.S.: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 29 U.S.: Market Size, By Access, 2015-2022 (USD Million)
Table 30 U.S.: Market Size, By Procedure, 2015-2022 (USD Million)
Table 31 Canada: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 32 Canada: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 33 Canada: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 34 Canada: Market Size, By Access, 2015-2022 (USD Million)
Table 35 Canada: Market Size, By Procedure, 2015-2022 (USD Million)
Table 36 Europe: Vascular Closure Devices Market Size, By Region, 2015-2022 (USD Million)
Table 37 Europe: Market Size, By Type, 2015-2022 (USD Million)
Table 38 Europe: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 39 Europe: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 40 Europe: Market Size, By Access, 2015-2022 (USD Million)
Table 41 Europe: Market Size, By Procedure, 2015-2022 (USD Million)
Table 42 E-3: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 43 E-3: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 44 E-3: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 45 E-3: Market Size, By Access, 2015-2022 (USD Million)
Table 46 E-3: Market Size, By Procedure, 2015-2022 (USD Million)
Table 47 RoE: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 48 RoE: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 49 RoE: Vascular Closure Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 50 RoE: Market Size, By Access, 2015-2022 (USD Million)
Table 51 RoE: Market Size, By Procedure, 2015-2022 (USD Million)
Table 52 Asia-Pacific: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 53 Asia-Pacific: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 54 Asia-Pacific: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 55 Asia-Pacific: Market Size, By Access, 2015-2022 (USD Million)
Table 56 Asia-Pacific: Market Size, By Procedure, 2015-2022 (USD Million)
Table 57 RoW: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 58 RoW: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 59 RoW: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 60 RoW: Market Size, By Access, 2015-2022 (USD Million)
Table 61 RoW: Market Size, By Procedure, 2015-2022 (USD Million)

List of Figures
Figure 1 Research Methodology: Global Vascular Closure Devices
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design: Global Vascular Closure Devices
Figure 6 Data Triangulation Methodology
Figure 7 Global Vascular Closure Devices Market, By Type (2017)
Figure 8 Global Market Size, By Access, 2017 vs 2022 (USD Million)
Figure 9 Global Market, By Procedure, 2017 vs 2022 (USD Million)
Figure 10 Geographical Snapshot of the Market
Figure 11 Rising Prevalence of Cardiovascular Diseases & Increasing Number of Regulatory Approvals are Major Factors Driving the Growth of the Market
Figure 12 Passive Approximators Segment to Account for the Largest Market Share in 2017
Figure 13 Femoral Access Segment Will Continue to Dominate the Vascular Closure Devices Market in 2022
Figure 14 Interventional Cardiology Segment to Account for the Largest Market Share in 2017
Figure 15 North America to Register the Highest CAGR in the Forecast Period
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Passive Approximators to Command the Largest Share and Register the Highest CAGR in the Global Vascular Closure Devices Market
Figure 18 Femoral Access Segment to Account for the Largest Share of the Vascular Closure Devices Market, By Access, in 2017
Figure 19 Interventional Cardiology Segment to Account for the Largest Share of the Market, By Procedure, in 2017
Figure 20 North America to Dominate the Market in 2017
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia-Pacific: Market Snapshot
Figure 24 RoW: Market Snapshot
Figure 25 MnM Dive - Vendor Comparison Chart
Figure 26 Terumo Corporation: Company Snapshot (2015)
Figure 27 Abbott Laboratories: Company Snapshot (2016)
Figure 28 Cardinal Health, Inc. Company Snapshot (2016)
Figure 29 Medtronic PLC: Company Snapshot (2016)
Figure 30 Merit Medical Systems, Inc.: Company Snapshot (2015)
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Tz MedicalInc. (U.S.)
  • Vasorum Ltd. (Ireland)
  • Inseal Medical Ltd. (Israel)
  • Morris Innovative Inc. (U.S.)
  • Essential Medical Inc. (U.S.)
  • Arstasis Inc. (U.S.)
  • Tricol Medical Inc. (U.S.)
  • Marine Polymer Technologies (U.S.)
  • Hemostasis LLC (U.S.)
  • Chitogen Inc. (U.S.)
  • Endocor GmbH (Germany)
  • Transluminal Technologies LLC (U.S.)
  • Hemoband Corporation (U.S.)
  • Vascualr Closure Systems Inc. (U.S.)
  • Advanced Vascular Dynamics (U.S.)
  • Scion Biomedical (U.S.)
  • Terumo Corporation (Japan)
  • Abbott Laboratories (U.S.)
  • Cardinal HealthInc. (U.S.)
  • Cardiva MedicalInc. (U.S.)
  • Medtronic PLC (Ireland)
  • Merit Medical Systems Inc. (U.S.)
  • Vivasure Medical Ltd. (Ireland)
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll